<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[99, 100] dyslipidaemia<br>[101, 102] MetS.<br>[226, 229] mean LDL size<br>[266, 272] decrease in insulin resistance by RF<br>[280, 284] HDL-C levels<br>[303, 308] cholesterol of larger HDL subclasses<br>[320, 324] mean LDL size;<br></td>
<td width=33%>
[99, 100] dyslipidaemia<br>[101, 102] MetS.<br>[226, 229] mean LDL size<br>[252, 254] hypotriglyceridemic capacity<br>[266, 272] decrease in insulin resistance by RF<br>[280, 284] HDL-C levels<br>[296, 302] cholesterol of small HDL particles.<br>[303, 308] cholesterol of larger HDL subclasses<br>[320, 324] mean LDL size;<br></td>
<td width=33%>
[14, 27] lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome.

<br>[35, 46] high-density lipoprotein cholesterol (HDL-C) levels<br>[62, 65] metabolic syndrome (<br>[92, 102] lipoprotein subfraction profile in patients with mixed dyslipidaemia and MetS.<br>[109, 119] low-density lipoprotein cholesterol (LDL-C)<br>[211, 214] lipoprotein subfraction profile<br>[226, 229] mean LDL size<br>[252, 254] hypotriglyceridemic capacity<br>[266, 272] decrease in insulin resistance by RF<br>[280, 284] HDL-C levels<br>[296, 302] cholesterol of small HDL particles.<br>[303, 308] cholesterol of larger HDL subclasses<br>[320, 324] mean LDL size;<br>[339, 341] HDL subfraction<br></td>
</tr>
